Impact of high disease activity on damage accrual and disease outcomes in childhood-onset systemic lupus erythematosus
By
Ninlapat Jidmahawong
Butsabong Lerkvaleekul
Kwanchai Pirojsakul
Soamarat Vilaiyuk
June 18, 2026
Clinical Scorecard: Effects of Prolonged High Disease Activity on Damage Accumulation and Clinical Outcomes in Pediatric Systemic Lupus Erythematosus
At a Glance
Category Detail
Condition
Key Mechanisms Cumulative high disease activity (HDAS) associated with damage accrual (source needed).
Target Population
Care Setting
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
M u l t i d i s c i p l i n a r y c a r e a p p r o a c h i n v o l v i n g p e d i a t r i c r h e u m a t o l o g i s t s a n d n e p h r o l o g i s t s ( s o u r c e n e e d e d ) .
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with HDAS require intensive immunosuppressive medications (source needed).
Clinical Best Practices
Related Resources & Content